1) endocannabinoid
内源性大麻素样物质
1.
Possible pharmacological mechanisms of endocannabinoids;
内源性大麻素样物质的可能作用机制
2) endocannabinoid
内源性大麻素
1.
The Biochemical Mechanism of Endocannabinoid System in Type 2 Diabetes and Obesity;
2 型糖尿病、肥胖症与内源性大麻素系统的生化作用
2.
Biochemical Mechanism of Endocannabinoid System in Type 2 Diabetes and Obesity
内源性大麻素系统在2型糖尿病与肥胖中生化机制
3.
Activation of Endocannabinoid System in Macrophages by Stimuli of Oxidized Low Density Lipoprotein
氧化型低密度脂蛋白诱导巨噬细胞内源性大麻素系统激活
3) endocannabinoid receptor 1
内源性大麻素受体1
1.
Expression and localization of endocannabinoid receptor 1 protein and mRNA in pancreas tissue of obese rats;
肥胖大鼠胰腺组织中内源性大麻素受体1蛋白和mRNA的表达及定位
4) Endocannabinoid system
内源性大麻素系统
1.
The further research about endocannabinoid system will give us a new therapeutic approaches to atherosclerosis.
内源性大麻素系统在体内外具有抗炎及免疫调节作用,能够影响动脉粥样硬化相关细胞的趋化、迁移、增殖、凋亡等,可能对动脉粥样硬化进展及血管再狭窄产生抑制作用,并对代谢综合征等动脉粥样硬化危险因素具有治疗作用,对内源性大麻素系统的深入研究有助于为动脉粥样硬化提供新的治疗手段。
6) endogenous digitalis-like substance
内源性洋地黄样物质
1.
Influence of repeated intravenous dripping different dose of Shengmai Injection on the blood serum concentration of endogenous digitalis-like substance in patients with heart failure;
不同剂量生脉注射液多次静点对心力衰竭患者内源性洋地黄样物质血浓度的影响
2.
Obiective To study the effect of median preoptic nucleus (MnPO)microinjection of Ang Ⅱon endogenous digitalis-like substance (EDLS)release and Na+,K+-ATPase activity of proximal tubule in spontaneously hypertensive rats (SHR).
目的探讨自发性高血压大鼠(SHR)正中视前核(MnPO)注射AngII对血清内源性洋地黄样物质和肾脏近球小管Na+,K+-ATPase活性的影响。
补充资料:内源性阿片样物质
内源性阿片样物质
endogenous opioids
即脑啡肽、内啡肽、强啡肽的总称。作用详见各条目解释。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条